Esoteric deals are gaining traction with drug and container ABS currently in the market.

Drug Royalty LP 1, a subsidiary of Toronto-based DRI Capital, is in the market with a $200 million securitization of 18 drug royalty streams generated from the global sales of 14 drugs.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.